Comparing two types of radiofrequency treatments for trigeminal neuralgia pain
Official title: The Efficacy and Safety of Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia: An Exploratory Study
Run by Alexandria University · NCT06779578 · Data updated 2026-11-12
This study is testing which type of radiofrequency treatment, bipolar or monopolar, works better for relieving pain in people with trigeminal neuralgia who haven't found relief from other medications.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Alexandria University Academic / other |
| Locations | 2 sites (Alexandria and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | June 1, 2025 |
| Study ends | September 1, 2025 |
| Registry record updated | January 17, 2025 |
| Trial ID | NCT06779578 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with classical trigeminal neuralgia who have not responded adequately to medical treatments.
✕Probably not a fit
Patients with trigeminal neuralgia caused by structural issues or those with atypical facial pain disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective exploratory study aims to compare the effectiveness of bipolar versus monopolar pulsed radiofrequency ablation in patients suffering from medically refractory trigeminal neuralgia. Participants will be randomly assigned to one of the two treatment groups, and their pain levels will be assessed at multiple intervals post-treatment using a nominal rating scale. The study will also evaluate patient satisfaction and monitor any complications that arise during or after the procedure. Data on sociodemographic factors and clinical history will be collected to better understand the patient population.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with refractory trigeminal neuralgia, potentially leading to significant pain relief.
How similar studies have gone: Other studies have shown promising results with radiofrequency ablation techniques for trigeminal neuralgia, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with a definitive diagnosis of classical TN based on the third version of the International Classification of Headache Disorders (ICHD-3). 2. Either purely paroxysmal classical TN or classical TN with concomitant chronic pain. 3. Patients with idiopathic TN, with symptomatic clinical topography of V2 and/or V3. 4. Patients with brain magnetic resonance imaging (MRI) unremarkable for structural etiology for the trigeminal pain. 5. Patients with medically refractory TN defined as pain persisting beyond three months at a level of ≥5/10 after monotherapy or polytherapy in appropriate medical doses. Exclusion Criteria: 1. Painful trigeminal neuropathy based on the third version of the International Classification of Headache Disorders (ICHD-3). 2. Trigeminal neuralgia with V1 symptomatic clinical topography. 3. Trigeminal neuralgia comorbid with other atypical facial pain disorders. 4. Structural TN e.g., due to vascular compression, posterior fossa tumors, central demyelination, …etc. 5. Patients exposed to previous radiofrequency procedures, as this may impair the nerve response to current PRF. 6. Patients who refused to participate in the study.
Where it's running
-
Alexandria University Faculty of Medicine
Alexandria, Egypt Recruiting -
Cairo University Kasr Alainy Faculty of Medicine
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Eman Hamdy, PhD
- Email: eman.ameen@alexmed.edu.eg
- Phone: +201061402092
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RP-008 with daily varenicline for trigeminal neuralgia
A new treatment approach tests RP-008 together with varenicline to see if it is safe, tolerable, and offers pain relief for adults with trigeminal neuralgia.
-
Using intravenous lacosamide to treat acute pain in trigeminal neuralgia
This study is testing if intravenous lacosamide can help relieve severe facial pain in people with trigeminal neuralgia who come to the emergency room.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
-
Comparing two methods for treating facial pain from trigeminal neuralgia
This study is testing whether a new combination of treatments for facial pain from trigeminal neuralgia works better than a single treatment to help adults feel less pain and improve their daily life.
-
Exploring the link between emotion, memory, and chronic facial pain
This study is trying to see how chronic facial pain affects memory and emotions by looking at brain changes in people with trigeminal neuralgia.
-
Evaluating Peripheral Nerve Stimulation for Postherpetic Neuralgia
This study is testing if a new nerve stimulation treatment can help people with postherpetic neuralgia manage their pain better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.